Readjudication of mortality data from the FOURIER trial suggests a higher risk for cardiovascular death with evolocumab (Repatha) among patients ...
Majority of Muscle Symptoms With Statins Not Due to Treatment Muscle pain in people taking a statin is typically not ...
Cholesterol Levels Lowering in US, but Disparities Emerge Cholesterol levels have improved among American adults over the past decade, but ...
A multi-biomarker risk score helps predict increased risk for future cardiovascular (CV) events as well as high-risk anatomy at revascularization ...
As many as one third of patients do not take their medications as directed, data indicate. In a study that ...
PCSK9 inhibitors, which are among the most effective therapies for reducing LDL cholesterol (LDL-C), are associated with a neutral effect ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
